Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;290(2):437-443.
doi: 10.1111/joim.13275. Epub 2021 Mar 21.

Arterial stiffness in acute COVID-19 and potential associations with clinical outcome

Affiliations

Arterial stiffness in acute COVID-19 and potential associations with clinical outcome

S Schnaubelt et al. J Intern Med. 2021 Aug.

Abstract

Background: Coronavirus disease 2019 (COVID-19) interferes with the vascular endothelium. It is not known whether COVID-19 additionally affects arterial stiffness.

Methods: This case-control study compared brachial-ankle pulse wave (baPWV) and carotid-femoral pulse wave velocities (cfPWV) of acutely ill patients with and without COVID-19.

Results: Twenty-two COVID-19 patients (50% females, 77 [67-84] years) were compared with 22 age- and sex-matched controls. In COVID-19 patients, baPWV (19.9 [18.4-21.0] vs. 16.0 [14.2-20.4], P = 0.02) and cfPWV (14.3 [13.4-16.0] vs. 11.0 [9.5-14.6], P = 0.01) were higher than in the controls. In multiple regression analysis, COVID-19 was independently associated with higher cfPWV (β = 3.164, P = 0.004) and baPWV (β = 3.532, P = 0.003). PWV values were higher in nonsurvivors. In survivors, PWV correlated with length of hospital stay.

Conclusion: COVID-19 appears to be related to an enhanced PWV reflecting an increase in arterial stiffness. Higher PWV might be related to an increased length of hospital stay and mortality.

Keywords: COVID-19; SARS-CoV-2; arterial stiffness; cardiovascular risk; pulse wave velocity.

PubMed Disclaimer

Conflict of interest statement

None of the authors declare any financial or intellectual conflict of interest.

Figures

Fig. 1
Fig. 1
Comparison of baPWVmax (a) and cfPWV (b) values between COVID‐19 and the matched non‐COVID‐19 patients (baPWV: P = 0.019; cfPWV: P = 0.007). BaPWVmax = maximum brachial‐ankle pulse wave velocity; COVID‐19 = coronavirus disease 2019; cfPWV = carotid femoral pulse wave velocity.
Fig. 2
Fig. 2
Comparison of baPWVmax (a) and cfPWV (b) values between survivors and nonsurvivors in the COVID‐19 cohort (baPWV: P = 0.004; cfPWV: P = 0.056). BaPWVmax = maximum brachial‐ankle pulse wave velocity; COVID‐19 = coronavirus disease 2019; cfPWV = carotid femoral pulse wave velocity.

References

    1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID‐19 and cardiovascular disease. Circulation 2020;141:1648–55. - PubMed
    1. Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, et al. Overcoming barriers: the endothelium as a linchpin of coronavirus disease 2019 pathogenesis? Arterioscler Thromb Vasc Biol 2020;40(8):1818–29. - PMC - PubMed
    1. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID‐19. Lancet 2020;395:1417–8. - PMC - PubMed
    1. Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, et al. COVID‐19‐associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience 2020;42(4):1021–49. - PMC - PubMed
    1. Goshua G, Pine AB, Meizlish ML, Chang C‐H, Zhang H, Bahel P, et al. Endotheliopathy in COVID‐19‐associated coagulopathy: evidence from a single‐centre, cross‐sectional study. Lancet Haematol 2020;7(8):e575–e582. - PMC - PubMed